Seizures, Eye, Diabetes Flashcards
which two agents have most benefits in CV outcomes for diabetes
empagliflozin and liraglutide
name DPP4 inhibitors- which do you use with caution in HF
saxagliptan (caution HF), sitagliptan, alogliptan
which diabetic agents cause hypoglycemia most
SUs, meglitinide (insulin secretagogue) insulin
name short acting insulins
aspart, glulisine, lispro
what renal fx is metformin CI? cautioned?
caution 60, CI less than 30
who are thiazoledinediones CI in?
heart failure
what is type 1 diabetes
deficiency of insulin due to autoimmune beta cell destruction
what is type 2 diabetes
insulin resistance with some degree of deficiency
what to start with diagnosis of type 2 diabetes
-A1C less than 8.5- lifestyle, metformin if not controlled in 2-3 months. If greater, start metformin right away and often need combination therapy
how many SMBG should be done per day for those on basal-bolus insulin (insulin more than once per day)
minimum 3x- mix of both pre and post prandial
SMBG in patients on oral therapy- with or without insulin
individualize based on risk of hypo, dosage changes or evaluation of new agents, concurrent illness. Infrequent is okay if achieving targets and not on agents that induce hypo. When not meeting targets, do some pre and post, individualized. If on oral and once daily insulin- test at least once daily at different times
how much activity is recommended in diabetes
greater than or equal to 150 minutes per week- exercise increases insulin sensitivity so adjust insulin accordingly (moderate exercise will likely decrease, but a stress response with intense exercise may increase blood glucose)
monitoring for people with diabetes
BP at all appropriate visits, foot exams yearly, A1C q3m, SCr and urine ACR yearly, eye exam q1-2 years,
which insulin regimen is inappropriate in type 1 diabetes
conventional
when around a meal do you give regular and rapid acting insulins
regular- 20-30 minutes before meal. rapid- shortly before or within 20 minutes of starting a meal
symptoms of mild-mod hypoglycemia- how to treat
sweating, tremors, tachycardia, hunger, N, weakness. Give 15g glucose- will raise BG about 2mmol within 20 minutes. Retest in 15, and if still below 4mmol/L, give another 15
symptoms of severe hypoglycemia- how to treat
neuroglycopenic sx like confusion, difficulty speaking, uncounsious, etc. Give 20g carbs/glucose, retest in 15 minutes, if still below 4 mmol/L give another 20
what is localized fat hypertrophy
result of frequent use of same injection site resulting in low or unpredictable absorption of insulin from that site
when should you aim to reach target a1c in newly diagnosed diabetes patients
3-6 months
MOA of SU and meglitinides
insulin secretagogues- squeeze pancreas to release more insulin
MOA of metformin and thiazolidinediones
decrease hepatic glucose production (shut off leaky liver) and increase tissue sensitivity to insulin
MOA of DPP4 inhibitors and GLP1 agonists
mimic or enhance incretin hormones. DPP4 augments the action on GLP1 by preventing its breakdown, while glp1 agonists increase insulin, suppress glucagon, and increase satiety by slowing gastric emptying
MOA acarbose
delay or prevents digestion of complex carbs
which antidiabetics are associated with weight gain?
SUs/insulin secretagogues, insulin, TZDs
which antidiabetics are associated with weight loss?
glp1 agonists, and modest with SGLT2 inhbitors. -almost all are weight neutral. Weight gain ones are SU/insulin secretagogues, insulin, TZDs
strongest evidence for antidiabetic agent with reducing mortality and macrovascular endpoints
metformin
SU with most risk of hypoglycemia
glyburide -also associated with most weight gain
which diabetic medications should be skipped if you skip a meal
meglitinides- repaglinide, etc- take them just prior to meal
TZD MOA in diabetes
PPAR gamma agonists- influence gene expression in cell leading ot enhaned insulin sensitivity and lower levels of blood glucose and circulating insulin
which antidiabetic meds are CI in bladder cancer (current or past)
pioglitazone, dapigliflozin
which groups of antidiabetic meds are associated with rare risk of pancreatitis
GLP1agonists and DPP4 inhibitors
diabetes meds CI in those with hx or fam hx of medullary thyroid cancer or multiple endocrine neoplasia syndrome
GLP1agonists